Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota.

Clinical trial NCT07306988 · RECRUITING

Trial details

NCT number: NCT07306988
Sponsor: Nanjing First Hospital, Nanjing Medical University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

HELICOBACTER PYLORI INFECTIONS Metabolic Syndrome

Start date: 2025-04-17
Primary completion: 2026-06-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.